Clinical Trials Publication of responses to the Public consultation - November 2009

Publication of responses to the Public consultation on draft revision 3 of Detailed guidance for the request for authorisation of a clinical trial on a medicinal product for human use to the competent authorities, notification of substantial amendments and declaration of the end of the trial. One respondent (Actogenix) asked for confidential treatment of the submission